
Jessica Rose
Articles
-
Dec 17, 2024 |
brownstone.org | Jessica Rose
On November 11, 2024, an article was published online in Business Wire pertaining to the launch of a clinical trial intended to test “Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults.” Question: Why is the word “Pandemic” in the title? The article provides information on the ARCT-2304 product which is a “sa-mRNA vaccine candidate formulated within a lipid nanoparticle (LNP).”So. Many. Questions.
-
Oct 25, 2024 |
jessicar.substack.com | Jessica Rose
In January 2024, a preprint was uploaded to the bioRxiv preprint server entitled: “The SV40 virus enhancer functions as a somatic hypermutation targeting element with potential oncogenic activity”. In a Venice.ai-summarized nutshell, the paper established the following:The SV40 enhancer has been found to function as a somatic hypermutation-targeting element with potential oncogenic activity.
-
Oct 15, 2024 |
academic.oup.com | Jessica Rose
We assessed the added benefit and waning effectiveness of a third COVID-19 vaccine dose (original formula) for preventing COVID-19-related outcomes. We used Medicare claims data to conduct a retrospective cohort study in U.S. community-dwelling Medicare Fee-for-Service beneficiaries aged ≥65 years during the BA.1/BA.2 Omicron period (December 19, 2021 – March 26, 2022).
-
Aug 15, 2024 |
jessicar.substack.com | Jessica Rose |Edouard Mathieu |Fiona Spooner |Saloni Dattani
First read this: Then look at the number of “Daily confirmed cases” worldwide according to Our World in Data: Then contextualize this with regard to “deaths”. The so-called increase in death rate being propagated by strange unelected individuals with investments to protect involves absolutely negligible numbers - and that’s assuming even these numbers aren’t fabricated. WHO knows, at this point. Public distrust is at an all-time high due to the COVID-19 “mismanagement debacle”.
-
Aug 3, 2024 |
jessicar.substack.com | Jessica Rose
A new preprint hit the presses on July 27, 2024 entitled: “Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans”. It was written by a group out of Australia and describes experiments that they did to show that the lipid nanoparticles used in the Moderna COVID-19 injectable products stick around and circulate on the blood. Shocker.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →